Filgrastim is marketed under several brand names, including Neupogen (Amgen), Imumax (Abbott Laboratories), Grafeel (Dr. Reddy's Laboratories), Neukine (Intas Biopharmaceuticals), Emgrast (Emcure Pharmaceuticals), Religrast (Reliance Life Sciences), Zarzio (Sandoz), Nufil (Biocon) and others.
Amgen Puerto Rico received FDA approval for bulk manufacturing facilities for Nepogen (Filgrastim), Neulasta (pegfilgrastim), Aranesp and Epogen.
Dr. Moore is a noted oncologist and hematologist primarily known for being the Principal Investigator in the development of filgrastim, marketed by Amgen under the brand name of Neupogen.